
Metsera, Inc.
MTSRNASDAQHealthcare
$70.50
$-0.25(-0.35%)
Market Cap$7.4B
P/E Ratio—
52W High$83.8599
52W Low$12.3
Metsera, Inc. (MTSR) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MTSR · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2024-12 | 2023-12 |
|---|---|---|
| Operating Activities | ||
| Net Income | ($0.21B) | ($0.05B) |
| Depreciation & Amort. | $0.00B | $0.00B |
| Stock-Based Comp. | $0.00B | $0.00B |
| Change in Working Capital | $0.03B | $0.00B |
| Net Cash from Operations | ($0.10B) | ($0.04B) |
| Investing Activities | ||
| Capital Expenditure | ($0.00B) | ($0.00B) |
| Purchases of Investments | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B |
| Net Cash from Investing | ($0.00B) | ($0.03B) |
| Financing Activities | ||
| Common Stock Repurchased | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.00B) | $0.00B |
| Net Cash from Financing | $0.38B | $0.12B |
| Free Cash Flow | ||
| Free Cash Flow | ($0.10B) | ($0.04B) |
| FCF Margin %(computed) | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Metsera, Inc. data
About Metsera, Inc. (MTSR) Cash Flow Statement
Metsera, Inc. generated operating cash flow of ($0.10B) and free cash flow of ($0.10B) for 2024 — a FCF margin of —. Capital expenditure was ($0.00B).
Frequently asked questions
MTSR · 4 questionsMetsera, Inc. generated free cash flow of ($0.10B) for 2024, down 181.8% year-over-year.
MTSR free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10